.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,435,944

« Back to Dashboard

Claims for Patent: 8,435,944

Title:Method and composition for transdermal drug delivery
Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
Inventor(s): Dipietro; Tony (Victoria, AU), Humberstone; Andrew (Victoria, AU), Gonda; Igor (South Yarra, AU), Watkinson; Adam (Victoria, AU), Setiawan; Kerrie (Victoria, AU), Wilkins; Nina (Victoria, AU)
Assignee: Acrux DDS Pty Ltd. (West Melbourne, Victoria, AU)
Application Number:11/445,463
Patent Claims: 1. A method of increasing the testosterone blood level of an adult male subject in need thereof comprising applying to at least one axilla of the subject, without occlusion by a patch device, a non-occlusive transdermal drug delivery composition consisting of: (a) a pharmaceutically effective amount of testosterone; (b) one or more lower alkyl alcohols, wherein the combined volume of the lower alkyl alcohols is more than 60% (v/v) of the composition; (c) one or more penetration enhancers selected from the group consisting of glycols, oleic acid, isopropyl myristate, cyclopentadecanone, sorbitan monooleate, octisalate, octyldimethyl-para-aminobenzoate, octyl para-methoxycinnamate, and combinations thereof; (d) one or more viscosity modulating agents; (e) optionally, an activator for the viscosity modulating agent; (f) optionally, an antiperspirant and/or deodorant agent; and (g) optionally, water wherein the composition is applied in an amount effective to achieve a testosterone blood level in the subject of at least 200 ng/dL.

2. The method of claim 1, wherein the adult male subject is suffering from androgen deficiency.

3. The method of claim 1, wherein the lower alkyl alcohol is selected from the group consisting of ethanol, isopropanol, and mixtures thereof, and wherein the combined volume of the lower alkyl alcohol(s) is more than 70% (v/v) of the composition.

4. The method of claim 3, wherein the combined volume of lower alkyl alcohol(s) is more than 80% (v/v) of the composition.

5. The method of claim 1, wherein the penetration enhancer is one or more selected from the group consisting of octyl dimethyl-para-aminobenzoate, octyl para-methoxycinnamate and octisalate.

6. The method of claim 1, wherein the penetration enhancer is octisalate.

7. The method of claim 1, wherein the viscosity modulating agent is selected from the group consisting of polyvinyl pyrrolidone and hydroxypropyl methyl cellulose.

8. The method of claim 1, wherein the viscosity modulating agent is polyvinyl pyrrolidone and is present in an amount of from 1% to 3% (w/v) of the composition.

9. The method of claim 1, wherein the amount of viscosity modulating agent is effective to increase the viscosity of the composition to within the range of from greater than the viscosity of water to less than 300 centipoise.

10. The method of claim 1, wherein the penetration enhancer is present in an amount of from 0.01 to 15% (w/v) of the composition.

11. The method of claim 1, wherein the penetration enhancer is isopropyl myristate.

12. The method of claim 11, wherein the lower alkyl alcohol is selected from the group consisting of ethanol, isopropanol, and mixtures thereof, and wherein the combined volume of lower alkyl alcohol(s) is more than 70% (v/v) of the composition.

13. A method of increasing the testosterone blood level of an adult male subject in need thereof comprising applying to at least one axilla of the subject, without occlusion by a patch device, a non-occlusive transdermal drug delivery composition consisting of: (a) a pharmaceutically effective amount of testosterone; (b) one or more lower alkyl alcohols, wherein the combined volume of the lower alkyl alcohol(s) is more than 60% (v/v) of the composition; (c) one or more penetration enhancers selected from the group consisting of octisalate, octyldimethyl-para-aminobenzoate and octyl para-methoxycinnamate; (d) one or more viscosity modulating agents, in an amount effective to increase the viscosity of the composition to within the range of from greater than the viscosity of water to less than 300 centipoise; and (e) optionally, water wherein the composition is applied in an amount effective to achieve a testosterone blood level in the subject of at least 200 ng/dL.

14. The method of claim 13 wherein the penetration enhancer is present in an amount of from 0.01% to 15% (w/v) of the composition.

15. The method of claim 14 wherein the penetration enhancer is octisalate.

16. The method of claim 15, wherein the lower alkyl alcohol is selected from the group consisting of ethanol, isopropanol, and mixtures thereof.

17. The method of claim 16 wherein the combined volume of lower alkyl alcohol(s) is more than 70% (v/v).

18. The method of claim 17 wherein the combined volume of lower alkyl alcohols(s) is more than 80% (v/v).

19. The method of claim 18 wherein the viscosity modulating agent is polyvinyl pyrrolidone.

20. The method of claim 19 wherein the polyvinyl pyrrolidone is present in an amount of from 1% to 3% (w/v) of the composition.

21. The method of claim 13, wherein the adult male subject is suffering from androgen deficiency.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc